Venkata Satagopam is a Senior Research Scientist and Head of the Clinical & Translational Informatics Group at the Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, where he has worked since 2013. He earned his PhD in Bioinformatics from the Technical University of Munich (TUM) after completing a Master’s in Pharmaceutical Sciences in India. Venkata began his career as a lecturer before moving into bioinformatics roles at LION bioscience AG and later as Senior Bioinformatics Scientist at EMBL Heidelberg. His research focuses on advancing digital health through IT solutions, data science, and biomedical informatics, with expertise in large-scale data integration, clinical and translational data harmonisation, disease maps, AI, deep learning, and high-performance computing. He has co-founded ITTM S.A. as CTO, coordinated the Luxembourg ELIXIR Node, and contributed to numerous European and international projects such as IMI-eTRIKS, AETIONOMY, NCER-PD, and CLINNOVA. Author of over 100 peer-reviewed publications (h-index 29), Dr. Satagopam is an associate editor for Frontiers journals, Fellow of FIAS, and Co-chair of ISCB’s Education Committee. His achievements include developing widely used biomedical databases and platforms, supervising numerous PhD and postdoctoral researchers, and organizing major conferences and hackathons.
Reinhard Schneider is Professor in Bioinformatics and the Head of the Bioinformatics Core group at the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg. He also leads the Luxembourg ELIXIR Node since 2017. He earned his Ph.D. in biology from the University of Heidelberg, Germany, and has published over 200 research papers. Schneider’s career spans leadership roles in academia and industry. Between 1994 and 2010, he served as Team Leader at the European Molecular Biology Laboratory (EMBL) in Heidelberg, where he directed the “Data Integration and Knowledge Management” group. Before joining EMBL, he co-founded LION bioscience AG in Heidelberg, acting as Chief Information Officer and overseeing global software development. He later became CEO of LION bioscience Research Inc. in Cambridge, Massachusetts, where he implemented IT-based knowledge management systems for Bayer’s gene-based R&D. Earlier in his career, he worked as a scientist in EMBL’s biocomputing department, studying protein structures and co-developing a large-scale automated sequence analysis system that became the foundation of LION’s software portfolio. He is also recognized as an expert in applying massively parallel computing to biological research. Schneider is an active member of the International Society for Computational Biology, where he served as Treasurer and currently chairs the Governance, Fundraising, and Finance Committee. Beyond academia, he contributes to several start-up initiatives in Germany and Luxembourg.